Add Row
Add Element
Glytain Logo
update
Glytain.com
update
Add Element
  • Home
  • Categories
    • Healthcare
    • Innovation
    • Digital
    • Marketing
    • Analysis
    • Insights
    • Trends
    • Empowerment
    • Providers
    • Tech News
    • Extra News
March 18.2025
3 Minutes Read

Highmark’s Shift from Exclusive Specialty Pharmacies to Tailored Solutions

Highmark Specialty Pharmacies partnership handshake in pharmacy setting.

Why Highmark is Rethinking Specialty Pharmacy Partnerships

Highmark, a significant player in the health insurance space, is reimagining its approach to specialty pharmacies. Historically tied to exclusive relationships with specific pharmacies, Highmark found this model increasingly limiting. According to Sarah Marche, senior vice president of pharmacy services, the traditional method aimed to consolidate patient drug utilization to achieve cost efficiencies. Instead, it may have compromised the quality of care available to patients with specialized needs.

Marche's epiphany came as she engaged with multiple specialty pharmacies that specialized in treating intricate conditions such as cystic fibrosis and cancer. She recognized a disparity in care; by confining patients to a singular pharmacy under an exclusivity agreement, Highmark was not only hampering patient outcomes but also potentially inflating costs. "I was receiving regular inquiries from various specialty pharmacies showcasing their unique capabilities to care for specific conditions," Marche recounted, leading her to eventually reevaluate the benefits of Highmark's exclusive contracts.

A New Collaborative Approach

As a solution, Highmark initiated a collaboration with Free Market Health around five years ago. This innovative partnership moves away from exclusivity, allowing members to connect with pharmacies tailored to their unique healthcare needs. Instead of mandating that all patients use a single provider, Highmark enables patients to choose pharmacies that specialize in managing their particular conditions. This bespoke approach not only better serves the patients but sets the stage for improved outcomes. Marche noted that patients suffering from specific ailments, like cancer, often perform better when treated by specialized oncological pharmacies.

This shift aligns with trends in healthcare towards patient-centered initiatives, where personalization is paramount. According to Marche, implementing this model means more than just financial savings; it also aims to enhance the healthcare experience, something that aligns with a broader movement in digital healthcare innovations.

The Impact of Technology on Healthcare

The partnership with Free Market Health, a tech-driven solution, aims to streamline how patients are matched with pharmacies. This model reflects emerging trends within the healthcare IT landscape, where digital solutions are becoming indispensable. The platform not only matches patients with appropriate pharmacies but also collects data to assess patient outcomes effectively. For instance, collecting information on patient journey and satisfaction could lead to long-term innovations in how healthcare benefits are administered in the future.

Looking Ahead: A Market-Driven Model

As more health providers recognize the limitations of traditional pharmacy agreements, a market-driven model emerges as a compelling alternative. By adopting this approach, healthcare stakeholders can find a balance between cost containment and patient satisfaction—an essential goal in today’s healthcare landscape. Mark Conklin, president of Free Market Health, emphasizes this transformation: “This model captures more value in a better-orchestrated ecosystem,” providing enhanced patient experiences alongside improved financial outcomes.

Conclusion

As Highmark continues to evaluate the implications of its new partnerships, it stands at the forefront of essential change within the industry. Embracing a more flexible, patient-centric approach can lead to improved outcomes and even cost reductions in the long term. Embracing innovative partnerships as healthcare trends evolve is critical for organizations seeking to stay competitive and effective in providing care.

Healthcare

Write A Comment

*
*
Related Posts All Posts

Over-the-Counter Continuous Glucose Monitors: Are They Worth It for Non-Diabetics?

Update Understanding the Rise of Over-the-Counter Continuous Glucose MonitorsOver-the-counter continuous glucose monitors (CGMs) have rapidly transformed from specialized devices for diabetics to accessible tools for anyone looking to monitor their glucose levels. While FDA-approved for both diabetic and non-diabetic users, new research indicates mixed effectiveness for healthy individuals.What Does Research Show About CGM Utility?A recent study conducted by Mass General Brigham examined the utility of CGMs in individuals without diabetes. Researchers found that while CGM readings aligned well with blood sugar measures in those with diabetes, the data was less reliable for those without the condition. The study sampled nearly 1,000 individuals, revealing that CGMs may help users understand how their lifestyle choices impact glucose levels, especially when examining short-term effects.The Dual Perspective: Insights from Users and ExpertsDr. Jorge Rodriguez, a lead author of the study, shared a personal anecdote about raising his glucose levels after eating a seemingly healthy soup that contained rice noodles. This anecdote illustrates a valuable learning opportunity for non-diabetics: CGMs could potentially inform dietary decisions even if they won’t definitively predict long-term health outcomes. However, Dr. Rodriguez emphasizes the necessity for more longitudinal studies to understand the broader implications of CGMs for non-diabetics.The Path Forward: Innovations Needed in Consumer CGMsThe question remains whether CGMs are worth using for those outside the diabetes spectrum. While they offer a snapshot of one’s dietary impacts on glucose levels, further innovation is needed to enhance their reliability and interpretability for the general public. Both healthcare professionals and tech innovators must collaborate to refine CGM technology, making it a genuinely useful tool for non-diabetics.Final Thoughts: Is a CGM Right For You?As CGMs become mainstream, understanding their benefits and limitations is crucial. Individuals considering using CGMs should weigh the insights they offer against their needs and health goals. Ultimately, these devices may provide valuable real-time feedback on lifestyle choices, opening new avenues for health management.

Leadership Changes in Pharma: What You Need to Know

Update Exciting Changes in the Pharma Industry The pharmaceutical sector is buzzing with movement as companies shuffle their leadership and talent. Among the latest news, enGene has made a significant addition to its team by hiring Hussein Sweiti as their new chief medical officer. Sweiti, who previously served as the global medical head for oncology clinical development at Johnson & Johnson, is expected to bring valuable expertise to enGene, which focuses on innovative solutions in the treatment landscape. Why Leadership Changes Matter Leadership transitions within pharmaceutical companies can have ripple effects throughout the industry and beyond. These changes not only influence company culture but can also impact the direction of research and development initiatives. With seasoned leaders like Sweiti stepping into these roles, companies may experience shifts in strategy that could lead to breakthroughs in drug development and patient care. Stay Ahead of the Trends As the landscape of pharmaceutical jobs continues to evolve, it’s crucial for professionals in the field to stay updated with these changes. Knowing who is stepping into key roles can provide insights into market directions and company strategies. This is an opportunity for job seekers and industry veterans alike to network effectively, drawing on strong leadership as a means to propel their careers forward. Community Spotlight Engagement in reporting these transitions fosters a greater connection within the pharma community. Sharing these updates through forums or platforms creates opportunities for collaboration and encourages a sense of camaraderie among professionals. Whether it’s celebrating a colleague’s promotion or announcing new hires, each story adds to the rich tapestry of our industry. Call for Contributions Have any exciting updates or personnel changes in your company? Don’t hesitate to share them! Everyone in the industry is eager to know about the comings and goings that shape the future of healthcare.

What You Should Know About Pharma Job Market Changes and Trends

Update A Snapshot of Transition in Pharma Careers The pharmaceutical industry is in a state of flux, marked by a notable series of job hirings and turnarounds that signal shifting trends in employment. Recently, enGene appointed Hussein Sweiti as chief medical officer after a prolific tenure at Johnson & Johnson. This rapid hiring reflects broader changes within the sector, as many companies adapt to new market demands and operational imperatives. Understanding the Evolving Job Market Despite the booming revenues of the pharmaceutical industry—projected over $1 trillion this year—the job market is experiencing a contradictory decline. According to recent data, job postings related to the evolving nature of pharmaceutical work have dropped, with a 0.7% decrease observed in Q2 2024 alone. Even more concerning is the 12% year-over-year decline in job postings within the biotech sector as reported by BioSpace. As traditional roles face increased competition and restructuring, many qualified professionals find themselves vying for fewer positions. The Rise of Digital Roles On the brighter side, new opportunities continue to emerge within the pharmaceutical landscape, particularly in technology-driven roles. Positions requiring expertise in data science and artificial intelligence are on the rise, contributing to the steady growth of certain specialized fields. Data analytics and machine learning are integral as companies move towards modernizing their research and development processes, an essential shift in a rapidly digitizing economy. Repercussions of Layoffs However, as companies like Merck and Pfizer announce significant layoffs, the landscape remains daunting for many professionals. Merck's decision to cut 6,000 jobs reflects a larger trend of restructuring to enhance efficiencies in R&D amid competitive pressures. Experts caution that these layoffs may persist through 2025, driven by market uncertainties and economic challenges. Many fear these shifts may further complicate the job search for new entrants in the field. Finding Your Place in the Future of Pharma While the landscape appears challenging, awareness of trends can empower professionals. Understanding the distribution of roles—where demand is concentrated—is crucial. Individuals skilled in regulatory affairs, compliance, and gene therapy are seeing increased demand. Job seekers can navigate this evolving market by honing in on areas of growth and embracing continuous learning. In conclusion, the pharmaceutical job market, while turbulent, presents distinct opportunities for those willing to adapt and innovate. Keeping abreast of industry changes, developing key competencies, and proactively networking may create the pathways to success in this dynamic environment. Embracing the journey with openness may enable individuals to turn these challenges into unique career opportunities.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*